Print Page | Sign In
Liza Brown, DO
Share |

Liza Brown, DO is a native of Florida. She received her undergraduate degree in Psychosocial sciences at the University of South Florida in Tampa. She worked at Moffitt Cancer Center for one year performing Melanoma research prior to attending medical school at Lake erie college of medicine in Bradenton FL. She completed her Internship at Largo medical center, followed by a clinical dermatology fellowship year. She is currently a third year dermatology resident at Larkin Community Hospital and plans to work in the Tampa area after she graduates.

 

Medical Dermatology Update

This lecture will introduce basic approaches to complex medical dermatology with specific diseases being reviewed. 

Objectives:

  1. How to manage and identify complex medical dermatology cases
  2. Learn various presentations and variations of skin conditions
  3. New treatments on the horizon
  4. Review histopathology of unique and difficult cases
  5. Explore different treatment options for difficult to manage cases
  6. Diagnosis and pathophysiology of select diseases

Needs:

  1. New advances in dermatologic treatment
  2. Availability of new medication(s) and indication(s)
  3. Advances in medical knowledge
  4. New methods of diagnosis or treatment
  5. Development of new technology
  6. Legislative, regulatory, or organizational changes effecting patient care

References: 

  1. Bolognia, Jean L., et al. “Dermatology” Section 4, Chapter 20, pg 323-332. Mosby Elsevier. 2008.
  2. Chong, Huey Ti, et al. “Cost-Effectiveness analysis of HLA-B*58”. Pharmacogenetics and Genomics, 2017, p. 1, doi:10.1097/fpc.0000000000000319.
  3. Bolognia 2nd edition, North, Paula E, Kincannon, Jay. Section 18, Chapter 114, pg. 1788.
  4. Weedon’s Skin Pathology, Weedon, David. Section 7, Chapter 38, pg. 920.
  5. Bolognia 2nd Edition – Section 7/42, pg. 583.
  6. Carter, A., Orgega-Loayza, AG., Barrett, J., Nunley, J., “Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach”. Clinical and Experimental Dermatology. Doi:10.1111/ced.12729.
  7. Speeckaert MM, Devreese KMJ, Vanholder RC, Dhondt A. “Fondaparinux as an alternative to vitamin K antagonists in haemodialysis patients”. Nephrology Dialysis Transplantation. 2013;28(12):3090-3095. Doi:10.1093/ndt/gft293.

Core Competencies: 1, 2, 3, 4, 6, 7

Disclosures: No disclosures provided by speaker

2902 North Baltimore Street | P.O. Box 7525 | Kirksville, Missouri 63501

660-665-2184 | 1-800-449-2623 | 660-627-2623